Louis Guzzi, MD
Critical Care Medicine · Orlando, FLNPI 1215923180
Payments from drug & device makers
Across 862 payments — averaging $736.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$222K
- La Jolla Pharmaceutical Company$101K
- Edwards Lifesciences$97K
- Biomerieux Inc$95K
- Acelrx Pharmaceuticals, Inc.$31K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$31K
- plus $59K from 25 others
Across 2 payments — averaging $2437.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biomerieux Inc$5K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 305 | $221,846 |
| La Jolla Pharmaceutical Company | 96 | $100,724 |
| Edwards Lifesciences | 140 | $96,719 |
| Biomerieux Inc | 87 | $95,089 |
| Acelrx Pharmaceuticals, Inc. | 41 | $31,122 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 58 | $30,803 |
| BD | 16 | $19,312 |
| Baudax Bio Inc. | 17 | $14,093 |
| Fresenius Kabi USA, LLC | 30 | $11,760 |
| BTG International Inc. | 2 | $6,703 |
| Gilead | 1 | $2,200 |
| Abiomed | 19 | $901 |
| Portola Pharmaceuticals, LLC | 1 | $900 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $594 |
| Smiths Medical ASD, Inc. | 1 | $518 |
| Merck | 8 | $258 |
| Nxstage Medical, Inc. | 3 | $241 |
| Boehringer Ingelheim | 2 | $221 |
| Melinta Therapeutics, LLC | 11 | $177 |
| Medtronic(2 entities) | 3 | $172 |
| Genentech USA, Inc. | 1 | $129 |
| Mallinckrodt Hospital Products Inc. | 1 | $108 |
| Ferring Pharmaceuticals Inc. | 1 | $101 |
| Novo Nordisk | 1 | $99 |
| Johnson & Johnson | 1 | $98 |
| Getinge USA Sales, LLC | 4 | $78 |
| Nuwellis, Inc. | 2 | $39 |
| AbbVie | 1 | $22 |
| Pentax Of America, Inc. | 1 | $18 |
| Boston Scientific | 1 | $14 |
| Biolife, L.L.C. | 6 | $0 |
How this compares
$635,061 in reported general payments places this provider in the 95th percentile of 618 critical care medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Orlando
- Amay ParikhOrlando$588K
- Omid ZadOrlando$325K
- Maria CarrilloOrlando$144K
- Charles HunleyOrlando$116K
- Arnaldo Lopez-RuizOrlando$92K
- Martin ZamoraOrlando$86K
- Dmitriy ZubkusOrlando$46K
- Hammad BhattiOrlando$41K
- Jeffrey LevyHollywood$19M
- Ahmad AswadMiami$6.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.